Endometrial cancer is the most common gynecologic cancer, with more than 69,000 cases diagnosed in the U.S. in 2025 and ...

Gastric cancer remains one of the leading causes of cancer-related mortality worldwide, primarily due to late-stage diagnosis ...

For decades, cancer screening has relied on imaging, bloodwork, and invasive testing. Now, one biotech company is taking a different approach. They’re combining dogs, breath samples, and AI to help ...

Researchers are calling for the application of locally driven strategies, supported by stronger regional evidence, to improve early cancer detection and precise care.

Endometrial cancer is the most common gynecologic cancer, with more than 69,000 cases diagnosed in the U.S. in 2025 and increasing up to 3% annually.

Pigeons are inspiring a new wave of AI for medical diagnostics. Researchers are studying how these birds process visual ...

Recent advances in the field of medical imaging and computational neuroscience have transformed the landscape of brain pathology detection. The application ...

If you can’t prevent cancer, the best chances of treating or surviving it may come down to finding a tumor early when it hasn’t yet spread. A new test called Cancerguard offers to screen for more than ...

For decades, cancer screening has relied on individual tests such as mammograms, colonoscopies, Pap smears, low-dose CT scans, and PSA testing. However, advances in genomic technology have led to the ...

An experimental pancreatic cancer drug has ignited hope in a field desperate for new treatments. Compared with traditional chemotherapy, a pill called daraxonrasib nearly doubled the survival time of ...

BOSTON, June 08, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision ...